Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fisher Paykel Healthcare | New Zealand | Salute | Attrezzature e forniture medicali | 22,20 Mrd NZ$ | 123,4x | -3,71 | 37,95 NZ$ | 0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -7,8% Ribasso | Fai l’upgrade a Pro+ | |
EBOS | New Zealand | Salute | Prodotti farmaceutici | 7,13 Mrd NZ$ | 23,5x | 3,8 | 36,60 NZ$ | 0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 7,7% Rialzo | Fai l’upgrade a Pro+ | |
Summerset | New Zealand | Salute | Fornitori e servizi sanitari | 3,06 Mrd NZ$ | 7,5x | 0,15 | 12,82 NZ$ | 1,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 13,5% Rialzo | Fai l’upgrade a Pro+ | |
Ryman Healthcare | New Zealand | Salute | Fornitori e servizi sanitari | 3 Mrd NZ$ | -36x | 0,25 | 4,40 NZ$ | 0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 32,2% Rialzo | Fai l’upgrade a Pro+ | |
Oceania Healthcare | New Zealand | Salute | Fornitori e servizi sanitari | 533,04 Mln NZ$ | -25,4x | 0,17 | 0,74 NZ$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 23% Rialzo | Fai l’upgrade a Pro+ | |
AFT Pharma | New Zealand | Salute | Prodotti farmaceutici | 295,99 Mln NZ$ | 27,6x | -0,8 | 2,80 NZ$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 33% Rialzo | Fai l’upgrade a Pro+ | |
Pacific Edge | New Zealand | Salute | Ricerca medica e biotecnologica | 95,81 Mln NZ$ | -3,5x | -0,33 | 0,12 NZ$ | -1,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 29,2% Rialzo | Fai l’upgrade a Pro+ | |
Radius Residential Care | New Zealand | Salute | Fornitori e servizi sanitari | 61,26 Mln NZ$ | -7,2x | 0,03 | 0,21 NZ$ | -4,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Cannasouth | New Zealand | Salute | Ricerca medica e biotecnologica | 32,39 Mln NZ$ | -2,8x | -0,13 | 0,10 NZ$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Promisia Healthcare | New Zealand | Salute | Fornitori e servizi sanitari | 19,20 Mln NZ$ | 9,6x | 0 | 0,37 NZ$ | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
BLIS Tech | New Zealand | Salute | Prodotti farmaceutici | 19,19 Mln NZ$ | 15x | 0,02 | 0,01 NZ$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Truscreen | New Zealand | Salute | Attrezzature e forniture medicali | 12,71 Mln NZ$ | -5,5x | -0,19 | 0,02 NZ$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Rua Bioscience | New Zealand | Salute | Prodotti farmaceutici | 5,57 Mln NZ$ | -0,5x | 0 | 0,03 NZ$ | -2,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Greenfern Industries | New Zealand | Salute | Fornitori e servizi sanitari | 2,29 Mln NZ$ | 2,3x | 0,02 NZ$ | 5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |